Bipolar Clinical Trials

210 recruitingLast updated: June 18, 2026

There are 210 actively recruiting bipolar clinical trials across 44 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4, Phase 1, Early Phase 1. Top locations include Atlanta, Georgia, United States, Houston, Texas, United States, Miami, Florida, United States. Updated daily from ClinicalTrials.gov.


Bipolar Trials at a Glance

210 actively recruiting trials for bipolar are listed on ClinicalTrialsFinder across 6 cities in 44 countries. The largest study group is Not Applicable with 99 trials, with the heaviest enrollment activity in Atlanta, Houston, and Miami. Lead sponsors running bipolar studies include Massachusetts General Hospital, VA Office of Research and Development, and Shanghai Mental Health Center.

Treatments under study

About Bipolar Clinical Trials

Looking for clinical trials for Bipolar? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bipolar trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bipolar clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 210 trials

Recruiting
Phase 4

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

SchizophreniaMajor Depressive DisorderBipolar Disorder+2 more
Neurocrine Biosciences50 enrolled22 locationsNCT07105111
Recruiting

Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers

DepressionHealthy VolunteersAnxiety Disorders+2 more
National Institute of Mental Health (NIMH)16,000 enrolled1 locationNCT00024635
Recruiting
Not Applicable

Time Restricted Eating (TRE) in Bipolar Disorder

Bipolar Disorder DepressionBipolar Disorder (BD)Overweight (BMI > 30)
Massachusetts General Hospital40 enrolled1 locationNCT07211217
Recruiting
Phase 3

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

DepressionBipolar I Disorder
AbbVie380 enrolled81 locationsNCT04777357
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

Bipolar DisorderMania
Bristol-Myers Squibb424 enrolled103 locationsNCT07140913
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Bipolar Disorder Type I With Mania or Mania With Mixed Features
Bristol-Myers Squibb274 enrolled78 locationsNCT06951711
Recruiting
Phase 2

A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)

Bipolar Disorder
Eli Lilly and Company400 enrolled87 locationsNCT07286175
Recruiting
Phase 3

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

SchizophreniaBipolar I Disorder
Alkermes, Inc.220 enrolled47 locationsNCT05303064
Recruiting
Phase 3

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Bipolar Disorder Type I With Mania
Bristol-Myers Squibb450 enrolled173 locationsNCT06929273
Recruiting
Phase 3

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Bipolar DisorderBipolar I DisorderBipolar II Disorder+1 more
Xenon Pharmaceuticals Inc.400 enrolled28 locationsNCT07172516
Recruiting
Phase 2

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder

Bipolar 1 Disorder
Rapport Therapeutics Inc.250 enrolled22 locationsNCT07046494
Recruiting

FOCUS Bipolar: Families Opening Conversations for Understanding Signs

Bipolar Disorder (BD)Bipolar Disorder I or IIScreening Tool+1 more
University of Texas Southwestern Medical Center200 enrolled1 locationNCT07622927
Recruiting
Not Applicable

Flumazenil for Benzodiazepine Reversal in Electroconvulsive Therapy

Autobiographical MemoryDepression - Major Depressive DisorderTreatment Outcome+6 more
Anders Jørgensen145 enrolled1 locationNCT07619092
Recruiting
Not Applicable

Efficacy and Safety Assessment of Temporal Interference Stimulation to Improve Bipolar Depression

Bipolar Depression
First Affiliated Hospital of Zhejiang University160 enrolled1 locationNCT07021508
Recruiting
Not Applicable

Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disorder Comorbid With Obesity

Bipolar Disorder (BD)
First Affiliated Hospital of Zhejiang University70 enrolled1 locationNCT07589647
Recruiting
Not Applicable

Personalized Mobile Cognitive Behavioral Therapy Application

DepressionBipolar DisorderAnxiety Disorders and Symptoms+1 more
Weill Medical College of Cornell University100 enrolled1 locationNCT05699525
Recruiting
Not Applicable

Immuno-Genetic, Inflammation, Retro-Virus, Environment

SchizophreniaBipolar Disorder
Pr. Marion Leboyer1,100 enrolled6 locationsNCT02878408
Recruiting
Phase 2

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

Bipolar I DisorderBipolar II Disorder
AbbVie195 enrolled31 locationsNCT06696755
Recruiting
Phase 2

Melatonin Versus Placebo for Bipolar Disorder

Bipolar Affective Disorder
Lars Vedel Kessing200 enrolled1 locationNCT07472075
Recruiting
Phase 2

Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder

Bipolar DisorderDelayed sleep-wake phase disorder
Leslie Swanson50 enrolled1 locationNCT06226025